Combinent Biomedical Systems focuses on the transvaginal delivery of drugs targeting women’s reproductive endocrinology disorders.
Combinent Biomedical Systems, Inc., a women's healthcare company, offers multi-segmented vaginal rings that allow the delivery of hydrophobic and hydrophilic molecules, proteins, and other large molecules. It focuses on transvaginal delivery of drugs targeting women's reproductive endocrinology disorders, as well as diabetes, obesity, and infectious diseases. Combinent Biomedical Systems, Inc. was incorporated in 2000 and is based in Lexington, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 17, 2009 | Series Unknown | $500K | 2 | — | — | Detail |
May 8, 2007 | Series A | $3M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Vimac Ventures | — | Series Unknown |
Commons Capital | — | Series Unknown |